FDA Suggests Supplement Firms Use MedDRA Internally For AER Data
This article was originally published in The Tan Sheet
Executive Summary
FDA suggests supplement firms keep internal records of adverse event data with the same coding system for medical conditions and symptoms that the agency uses
You may also be interested in...
Herbalife's Frankos Sees GMP Challenges In New Light After Leaving FDA
Vasilios "Bill" Frankos, former director of FDA's Division of Dietary Supplement Programs, left his mark on the industry after shepherding the supplement good manufacturing practices final rule from development to publication and through implementation
Herbalife's Frankos Sees GMP Challenges In New Light After Leaving FDA
Vasilios "Bill" Frankos, former director of FDA's Division of Dietary Supplement Programs, left his mark on the industry after shepherding the supplement good manufacturing practices final rule from development to publication and through implementation
Herbalife's Frankos Sees GMP Challenges In New Light After Leaving FDA
Vasilios "Bill" Frankos, former director of FDA's Division of Dietary Supplement Programs, left his mark on the industry after shepherding the supplement good manufacturing practices final rule from development to publication and through implementation